Image

Machine Learning-based Longitudinal Study of Post-ICU Syndrome Development Trajectory in Critically Ill Patients and Construction of Clinical Early Warning Models: a Research Protocol for Longitudinal Study

Machine Learning-based Longitudinal Study of Post-ICU Syndrome Development Trajectory in Critically Ill Patients and Construction of Clinical Early Warning Models: a Research Protocol for Longitudinal Study

Not Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This project intends to track and evaluate whether post-ICU syndrome will occur 7 days, 1 month, 3 months and 6 months after ICU patients are transferred out of the ICU through a longitudinal study, apply the latent category growth model to identify different trajectory patterns of post-ICU syndrome in critically ill patients, and use modern machine learning models to build an early warning model of the trajectory patterns of post-ICU syndrome.

Eligibility

Inclusion Criteria patients :

  • Length of stay in ICU ≥24h;
  • Age ≥18 years old;
  • Conscious when leaving ICU, communicating with investigators without barriers;
  • Informed consent. Family members:
  • One family member ≥18 years of age was selected for each patient;
  • Assume the main role of caring for patients and medical decision-making;
  • No history of mental illness or other serious organic diseases;
  • Informed consent and voluntary participation in this study.

Exclusion Criteria patients :

  • Have been in ICU for more than 24h within 3 months before this admission;
  • Transferred to another ICU;
  • Cognitive impairment existed before ICU admission (BDRS \> 4 points);
  • Severe hearing impairment, dysarthria, etc., which cannot be followed up;
  • Unable to complete the questionnaire survey due to serious illness.

Family members:

  • Family members refuse to participate in the study due to their own reasons;
  • Severe hearing and language impairment, unable to cooperate with researchers.

Study details
    Intensive Care Unit Syndrome
    Prediction
    Cognitive Impairment
    Sleep Disorder
    Memory Disorders

NCT06427265

The Affiliated Hospital Of Guizhou Medical University

4 July 2026

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.